Physician profile
Phi-Yen Vu
NPI 1427605567
$7,760.44
in general payments reported to CMS, 2019-2025
22 companies · $874 in 2025
The $874 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,997 · 2022: $2,367 · 2023: $1,269 · 2024: $1,254 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,396.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,206.49 | 2021-2025 | |
| Genzyme Corporation | $1,558.61 | 2021-2025 | |
| Lilly USA, LLC | $1,041.80 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $410.99 | 2021-2022 | |
| Incyte Corporation | $361.73 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $268.40 | 2022 | |
| Pfizer INC. | $245.39 | 2021-2023 | |
| Janssen Biotech, INC. | $230.65 | 2022-2025 | Tremfya |
| Amgen INC. | $208.20 | 2021-2024 | Otezla |
| Regeneron Healthcare Solutions, INC. | $205.75 | 2024-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $197.22 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $165.80 | 2021-2024 | Blu-U |
| Vyne Pharmaceuticals INC. | $140.79 | 2021 | |
| Arcutis Biotherapeutics, INC. | $136.12 | 2024-2025 | Zoryve |
| Genentech USA, INC. | $104.03 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $75.80 | 2023 | Ycanth |
| Leo Pharma INC. | $69.14 | 2021-2022 | |
| Almirall LLC | $65.15 | 2021-2022 | |
| Biofrontera INC. | $19.86 | 2022 | |
| Strata Skin Sciences, INC. | $18.32 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.04 | 2022 | |
| Mayne Pharma Commercial LLC | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phi-Yen Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.